• Assessment and Characterization of Gaps in Literature of Resource Utilization and Economic Burden in Inflammatory Myopathies

    May 1, 2016, 00:00

  • PSYCHOMETRIC VALIDATION OF THE DIABETES KNOWLEDGE TEST IN MEDICAID-ELIGIBLE ADULTS

    May 1, 2016, 00:00

  • The Real-World Cost-Effectiveness of Coronary Artery Bypass Grafting Versus Stenting in High-Risk Patients- Propensity Score Analysis of a Single Centre Experience

    May 1, 2016, 00:00

  • Analysis Of Indication Expansions For Orphan-Designated, FDA-Approved Drugs Launched In The United States Between 2005 And 2015

    May 1, 2016, 00:00

  • Characterizing Health Care Utilization, Direct Costs, and Comorbidities Associated with Interstitial Cystitis- A Retrospective Claims Analysis

    May 1, 2016, 00:00

  • ORAL ANTICOAGULANT USE- RESOURCE UTILIZATION AND THE OCCURRENCE OF BLEEDING EVENTS

    May 1, 2016, 00:00

  • THE EXPENDITURE AND REIMBURSEMENT OF ORPHAN DRUG IN TAIWAN- CHALLENGES AND OPPORTUNITIES

    May 1, 2016, 00:00

  • How to Measure ‘Opioid Relapse’ in Real-World Claims Data

    May 1, 2016, 00:00

  • Incidence Of Neutropenia In Patients Receiving Either Nab-Paclitaxel Plus Gemcitabine Or Folfirinox As First-Line Treatment For Metastatic Pancreatic Adenocarcinoma

    May 1, 2016, 00:00

  • SINGLE DOSE INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER- NICE RECOMMENDATIONS REVISITED

    May 1, 2016, 00:00

  • Bayesian Network Meta-Analysis on Prevention of Stroke For Patent Foramen Ovale Closure

    May 1, 2016, 00:00

  • EARLY OPIOID USE, PATIENT-REPORTED OUTCOMES, AND UTILIZATION AMONG OLDER ADULTS WITH NEW EPISODES OF CARE FOR LOW BACK PAIN

    May 1, 2016, 00:00

  • Influence of Perceived Physical and Mental Health Status and Co-Occurring Chronic Conditions on Health Care Expenditures Among Community-Dwelling Adults With Kidney Cancer in the United States- A Propensity Score Matched Analysis

    May 1, 2016, 00:00

  • Utilizing a Byod Mobile App to Collect Patient Diaries and Dosing Information in a Phase II Clinical Trial

    May 1, 2016, 00:00

  • SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF ULTRA-ORPHAN THERAPIES

    May 1, 2016, 00:00

  • The Impact of Different Approaches to Addressing Missing Items in Cancer Experience Surveys

    May 1, 2016, 00:00

  • Use Of Real-World Data To Estimate Cardiovascular Event Rates Among Non-Elderly Commercially Insured High Cardiovascular Risk Patients In The United States

    May 1, 2016, 00:00

  • PREVALENCE PATTERNS IN GYNECOLOGIC SCREENING AMONG FEMALE MEDICAID ENROLLEES

    May 1, 2016, 00:00

  • The Presence of Mental Health Conditions Among Patients with Congestive Heart Failure and the Impact on Health Outcomes- A Propensity Score Matched Study

    May 1, 2016, 00:00

  • CANADIAN PUBLIC REIMBURSEMENT OF BIOSIMILARS (REFERRED TO AS SUBSEQUENT ENTRY BIOLOGICS – SEBS – IN CANADA), AN UPDATE

    May 1, 2016, 00:00

  • Estimating The Societal Costs Associated With Glp-1ras In The United States For The Treatment of Type 2 Diabetes

    May 1, 2016, 00:00

  • Barriers and Facilitators to Diabetes Self-Management in a Primary Care Setting- Physician Perspective

    May 1, 2016, 00:00

  • COMPARING HOSPITAL PERFORMANCE FOR IN-HOSPITAL MORTALITY IN PNEUMONIA PATIENTS USING TRADITIONAL LOGISTIC REGRESSION AND MULTILEVEL MODELING APPROACH

    May 1, 2016, 00:00

  • Impact of Health-Related Quality of Life and Social Determinants on Yearly Influenza Immunization in the United States

    May 1, 2016, 00:00

  • Preventive Care Screening Patterns among Women with Medicaid

    May 1, 2016, 00:00

  • A Role For Pro-Based Patient Treatment Simulators In Observing Physician Treatment Of Pain And Discomfort

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS OF SAFETY ENGINEERED PERIPHERAL CATHETERS WITH AN INTEGRATED STABILIZATION PLATFORM UNDER THE PERSPECTIVE OF HOSPITALS IN BRAZIL

    May 1, 2016, 00:00

  • SHOULD THE GOVERNMENT INTERVENE IN THE IMPLEMENTATION ON SAFETY-ENGINEERED DEVICES? EVIDENCE FROM A COST-EFFECTIVENESS ANALYSIS OF NEEDLESTICK INJURIES

    May 1, 2016, 00:00

  • Association Between Affordable Care Act-Covered Preventive Care Use and Emergency Room Visits and Costs in Adults

    May 1, 2016, 00:00

  • Serum Vitamin D Deficiency among African American Women in the United States

    May 1, 2016, 00:00

  • MODELING ECODEVELOPMENTAL CONTEXT OF STDS/HIV RISK AND PROTECTIVE BEHAVIORS AMONG AFRICAN AMERICAN ADOLESCENTS

    May 1, 2016, 00:00

  • Economic Burden of Advanced Breast Cancer

    May 1, 2016, 00:00

  • COST-CONSEQUENCES ANALYSIS OF COFORMULATED ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE IN PATIENT POPULATIONS WITH DIFFERING RISK PROFILES

    May 1, 2016, 00:00

  • Caregiver Burden In Schizophrenia- Pooled Analysis Of The Involvement Evaluation Questionnaire Data For Paliperidone Palmitate 3-Month Formulation

    May 1, 2016, 00:00

  • An Assessment Of Follow-Up Visits And Use Of Psychosocial Services Among Foster And Non-Foster Children Starting Antipsychotic Therapy

    May 1, 2016, 00:00

  • Psychometric Properties of the Euroqol-5-Dimensions Questionnaire (EQ-5D-3L) Among Multiple Sclerosis Caregivers

    May 1, 2016, 00:00

  • FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN

    May 1, 2016, 00:00

  • Cost Comparison between the Manual System and Automated Dispensing Systems; How to Use Effective Health Technology at a Large Academic Hospital in Thailand

    May 1, 2016, 00:00

  • ISOLATION, IDENTIFICATION, AND ANTIMICROBIAL SUSCEPTIBILITY TESTING OF SALMONELLA FROM SELECTED POULTRY FARMS IN DEBRE ZEIT

    May 1, 2016, 00:00

  • CURATING AN ELECTRONIC HEALTH RECORD RESEARCH QUERY DEFINITION LIBRARY

    May 1, 2016, 00:00

  • EQUITY AND AFFORDABILITY- REIMBURSEMENT OF ECULIZUMAB IN THE IRISH HEALTH CARE SETTING

    May 1, 2016, 00:00

  • EARLY VIEW OF REAL-WORLD SUSTAINED VIROLOGIC RESPONSE RATES FOR NEW DIRECT ACTING ANTIVIRAL AGENTS IN HCV PATIENTS IN THE UNITED STATES VETERANS ADMINISTRATION HEALTH SYSTEM

    May 1, 2016, 00:00

  • ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO

    May 1, 2016, 00:00

  • EPIDEMIOLOGY AND ECONOMIC BURDEN OF ADVERSE DRUG REACTIONS IN CLINICAL PRACTICE- ROLE OF THE PHARMACIST

    May 1, 2016, 00:00

  • AN INTERIM ANALYSIS ASSESSING THE ASSOCIATION BETWEEN PATIENTS’ PERCEPTIONS OF SUCCESS WITH POST-OPERATIVE PAIN MANAGEMENT AND OVERALL EXPERIENCE WITH CARE AS MEASURED BY HCAHPS

    May 1, 2016, 00:00

  • RADIOFREQUENCY TECHNOLOGY- VALUE IN THE ORTHOPAEDIC OPERATING ROOM

    May 1, 2016, 00:00

  • Economic And Utilization Trends Among Esrd Patients With Anemia- Iv Iron And Erythropoiesis Stimulating Agents

    May 1, 2016, 00:00

  • Cytotoxic Activities And Pharmacological Interactions Of Natural Bile Acids With Doxorubicin In Human Breast Adenocarcinoma Cell Line

    May 1, 2016, 00:00

  • BIBLIOMETRIC ANALYSIS OF THE LATIN AMERICA SCIENTIFIC PRODUCTION OF HEALTH-RELATED QUALITY OF LIFE

    May 1, 2016, 00:00

  • Predictors And Prevalence Of Sleep Disturbance And Hypnotic Use In Persons With Cancer

    May 1, 2016, 00:00

  • Cost Effectiveness of Apixaban (Novel Oral Anti-Coagulant) Compared with Conventional Therapy for Stroke Prophylaxis among Renal Impaired Patients with Atrial-Fibrillation from Perspective of Us Third Party Payer

    May 1, 2016, 00:00

  • KNOWLEDGE, ATTITUDE, AND PRACTICES OF HEALTH CARE PROFESSIONALS REGARDING PHARMACOVIGILANCE IN PAKISTAN

    May 1, 2016, 00:00

  • Towards an Evidence Threshold at PCODR

    May 1, 2016, 00:00

  • Factors Associated with Health Care Utilization by Members of Qualified Health Plans- Emergency Room Versus Primary Care Provider Visits

    May 1, 2016, 00:00

  • Examination Of Equity In The Delivery Of Personalised Medicines

    May 1, 2016, 00:00

  • Prevalence Of Use Of Contraceptive Methods In Young Poor People From A Region Of Colombia

    May 1, 2016, 00:00

  • Effects of Education and other Socioeconomic Variables on Hiv Seroprevalence in Russia, India, South Africa, and The United States

    May 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Lurasidone And Olanzapine In The Treatment Of Schizophrenia

    May 1, 2016, 00:00

  • Incorporating User Experience Design into Electronic Clinical Outcome Assessment System Design

    May 1, 2016, 00:00

  • An Examination Of The Most Recent Uaga And Possible Effects On The Number Of Organs Available For Transplantation

    May 1, 2016, 00:00

  • Economic Burden of Unmanaged Chronic Cardiovascular Diseases in Brazilian Supplementary Health Care Perspective

    May 1, 2016, 00:00

  • Economic Burden Attributable to Obesity in Adult Patients with Rheumatoid Arthritis in the United States

    May 1, 2016, 00:00

  • Approvals, Discontinuations, and Price Analysis of Brand Breast Cancer Drugs in the United States (1990-2014)

    May 1, 2016, 00:00

  • Budget Impact Analysis Of Budesonide In The Treatment Of Asthma In Adult Population In Russian Federation

    May 1, 2016, 00:00

  • Are Oncology Drug Prices in the United States too High? A Targeted Review of the Literature

    May 1, 2016, 00:00

  • Assessing the Predictive Validity of Quality of Evidence Grades in Systematic Reviews. A Meta-Epidemiological Study

    May 1, 2016, 00:00

  • TREATMENT PREFERENCES OF PATIENTS WITH TYPE 2 DIABETES IN THE UNITED STATES- AN APPLICATION OF GOOD RESEARCH PRINCIPLES FOR DISCRETE CHOICE EXPERIMENTS

    May 1, 2016, 00:00

  • An Evaluation of Disability Progression and Quality of Life in Multiple Sclerosis Patients in Brazil and Mexico

    May 1, 2016, 00:00

  • Analysis Of Relationship Between Temperature Differences And Asthma Using Claims Database

    May 1, 2016, 00:00

  • Economic and Quality-of-Life Impact of a Pelvic Floor Physical Therapy Program for Women with Urinary Incontinence in a Middle Low-Income Neighborhood in Medellin, Colombia

    May 1, 2016, 00:00

  • SUMMARIZING THE BARRIERS AND SUPPORTING FACTORS TOWARDS ORGAN DONATION- A REVIEW OF THE LITERATURE

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS

    May 1, 2016, 00:00

  • Current Situation and Prospect of Pediatric Medicine in China

    May 1, 2016, 00:00

  • Transcatheter Aortic Valve Replacement In South-America- A Meta-Analysis of Real-Life Outcomes

    May 1, 2016, 00:00

  • IDENTIFYING BEST PRACTICES FOR USE OF TEXT DATA IN HEALTH ECONOMICS AND OUTCOMES RESEARCH USING NATURAL LANGUAGE PROCESSING

    May 1, 2016, 00:00

  • THE HIGH COST OF LOW BARIATRIC SURGICAL VOLUME IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2016, 00:00

  • INSIGHTS FOR CARE- USING REAL-WORLD DATA TO QUANTIFY DIABETES TREATMENT PATTERNS AND OUTCOMES IN AN URBAN HEALTH ECONOMY

    May 1, 2016, 00:00

  • Deriving Utility Weights from Patient-Reported Outcomes in Epilepsy

    May 1, 2016, 00:00

  • Association Of Deep Responses With Outcomes (Clinical / Non-Clinical) In Chronic Lymphocytic Leukemia- A Systematic Review

    May 1, 2016, 00:00

  • WILLINGNESS-TO-PAY TREATMENT TIME- PATIENT VERSUS NON-PATIENT PREFERENCES AND THE IMPACT OF ADAPTATION ON MONETARY VALUATION

    May 1, 2016, 00:00

  • BETTER EFFECTIVENESS OF HERPES ZOSTER VACCINE IN PREVENTING HERPES ZOSTER OPHTHALMICUS WITH OCULAR INVOLVEMENT

    May 1, 2016, 00:00

  • QUALITATIVE INTERVIEWS VERSUS SOCIAL MEDIA SEARCHES- COMPARING TWO APPROACHES FOR CONCEPT ELICITATION

    May 1, 2016, 00:00

  • Latest Trends In Design Of Clinical Trials For Real-World Health Economic Evidence Generation

    May 1, 2016, 00:00

  • The Influences of Access to Care and Geographic Factors on Adjuvant Endocrine Therapy use among Breast Cancer Survivors in Appalachia

    May 1, 2016, 00:00

  • Do formulary drug exclusion policies always save money? A literature review

    May 1, 2016, 00:00

  • Estimation Of Incidence Of Pancreatic Cancer By State And By Age Group In The United States

    May 1, 2016, 00:00

  • Development Of A Linked Database For Cystic Fibrosis Research By Integrating A Patient Registry With Administrative Claims Data

    May 1, 2016, 00:00

  • DOES PRACTICE MAKE PERFECT? DOES THE NUMBER OF NICE AND SMC SUBMISSIONS A COMPANY MAKES CORRELATE WITH SUCCESS RATES?

    May 1, 2016, 00:00

  • HOW VALUABLE IS A CANCER THERAPY? IT DEPENDS ON WHOM YOU ASK

    May 1, 2016, 00:00

  • USE OF LIPOSOMAL BUPIVACAINE IN PATIENTS UNDERGOING ORTHOPEDIC KNEE AND HIP PROCEDURES AT A COMMUNITY HOSPITAL

    May 1, 2016, 00:00

  • Use Of Real-World Data To Estimate Cardiovascular Event Rates Among Elderly High Cardiovascular Risk Patients With Medicare Supplemental Insurance In The United States

    May 1, 2016, 00:00

  • Cost Effectiveness of Primary Endocrine Therapy Against Surgery for Older Women with Primary Breast Cancer

    May 1, 2016, 00:00

  • European HTA, Pricing And Reimbursement Roadmaps- Revisited 2016

    May 1, 2016, 00:00

  • Inequalities in Acute Diarrheal Diseases Mortality in Children Under Five Years in Colombia

    May 1, 2016, 00:00

  • Costs With High CoST Drugs For Patients With Schizophrenia Attended By Brazilian Public Health System In Eleven Years Follow-Up

    May 1, 2016, 00:00

  • Indirect Comparison Of Pembrolizumab To Vemurafenib And Dabrafenib Monotherapy For First-Line Treatment Of Advanced Melanoma In Braf Mutation Positive Ipilimumab Naïve Patients

    May 1, 2016, 00:00

  • PHRMACEUTICAL DEVELOPMENT- AFRICA AN EMERGENT MARKET

    May 1, 2016, 00:00

  • The Role Of Sleep Quality Improvement Training Within Workplace Health Promotion

    May 1, 2016, 00:00

  • Communimetric Decision-Support Algorithms And Outcomes Monitoring Improves Clinical Outcomes For Youth With Serious Emotional Disturbance In Pennsylvania’s Community Behavioral Health System

    May 1, 2016, 00:00

  • Costs of Non-Adherence in Hypertensive Patients Affiliates to Health Insurance in Cartagena

    May 1, 2016, 00:00

  • Factors Influencing Resection in Locoregional Pancreatic Cancer Patients

    May 1, 2016, 00:00

  • PLAN FORMULARY COVERAGE AND DRUG CONSUMPTION OF LOW-INCOME SUBSIDY RECIPIENTS IN MEDICARE PART D

    May 1, 2016, 00:00

  • The Cost of Serious Adverse Events in Multi-Drug-Resistant Tuberculosis Treatment- Experience from Ethiopia

    May 1, 2016, 00:00

  • CHARACTERIZATION AND PATIENT-REPORTED PERCEPTIONS AND OUTCOMES OF INSULIN USE AMONGST PRE-INSULIN VERSUS INSULIN TYPE 2 DIABETES MELLITUS POPULATIONS IN UNITED STATES

    May 1, 2016, 00:00

  • USING READILY AVAILABLE ADMINISTRATIVE DATA ELEMENTS TO PREDICT FUTURE MEDICATION NON-ADHERENCE AMONG COPD PATIENTS WITH EMPLOYER-SPONSORED INSURANCE

    May 1, 2016, 00:00

  • QUALITY OF CARE AND HEALTH-RELATED QUALITY OF LIFE MEASURES IN DIABETIC PATIENTS WITH COMORBIDITIES

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS ANALYSIS OF PIPELINE® EMBOLIZATION DEVICE (PED) FOR THE TREATMENT OF UNRUPTURED INTRACRANIAL ANEURYSMS VERSUS STANDARD ENDOVASCULAR TREATMENT IN THE MEXICAN PUBLIC HEALTH CARE SYSTEM

    May 1, 2016, 00:00

  • A Systematic Review of the Impact of Adjuvant Antiparkinson Medications on Disability and Quality of Life of Patients with Parkinson’s Disease

    May 1, 2016, 00:00

  • Preference-Based Utilities for Adjuvant Melanoma in the United Kingdom and Australia

    May 1, 2016, 00:00

  • Comparative Performance of Anticholinergic Scales in Quantifying Anticholinergic Use in the Elderly

    May 1, 2016, 00:00

  • Quality-Adjusted Life Expectancy and Quality-Adjusted Life Expectancy Lost for Lung and Colon Cancer

    May 1, 2016, 00:00

  • THE INCREMENTAL EFFECT OF OVER-THE-COUNTER MEDICATIONS ON WORK PRODUCTIVITY AND HEALTH CARE RESOURCE UTILIZATION AMONG ADULTS WITH PAIN IN THE UNITED STATES

    May 1, 2016, 00:00

  • COST-COMPARISON OF TWO TRABECULAR MICRO-BYPASS STENTS VERSUS SELECTIVE LASER TRABECULOPLASTY OR MEDICATIONS ONLY FOR INTRAOCULAR PRESSURE CONTROL FOR PATIENTS WITH OPEN-ANGLE GLAUCOMA

    May 1, 2016, 00:00

  • ASSESSING THE POTENTIAL RISK OF SEROTONIN SYNDROME IN TAPENTADOL USERS

    May 1, 2016, 00:00

  • IDENTIFYING FACTORS ASSOCIATED WITH NEUROPATHIC CANCER PAIN AMONG CANCER PATIENTS

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS ANALYSIS OF PHARMACOLOGICAL TREATMENT PATHWAYS FOR TYPE 2 DIABETES DRUGS

    May 1, 2016, 00:00

  • Cost Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in United States Population- Results of the Improve-It Trial

    May 1, 2016, 00:00

  • VALUE OF INFORMATION METHODS FOR OPTIMAL TIMING OF BIOMARKER COLLECTION

    May 1, 2016, 00:00

  • CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA- AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN EXPERIENCE

    May 1, 2016, 00:00

  • Cost and Budget Impact of Topical Treatments for the Inflammatory Papules and Pustules of Mild to Moderate Rosacea in the Managed Care Setting

    May 1, 2016, 00:00

  • EFFECT OF HEALTH SECTOR FUNDING ON IMMUNIZATION SERVICES- FINDINGS FROM NIGERIA’S FEDERAL CAPITAL TERRITORY

    May 1, 2016, 00:00

  • First Treatment Success With Injectable Cefovecin Sodium In Dogs For Superficial Pyoderma, Wounds, And Abscesses In Different Dog Populations

    May 1, 2016, 00:00

  • A Population-Based Study of Radiotherapy use in the Last 30 Days of Life for Patients with Thoracic Cancers in Taiwan

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION VERSUS SURGICAL AORTIC VALVE REPLACEMENT- THE COREVALVE HIGH RISK TRIAL FROM A DUTCH PERSPECTIVE

    May 1, 2016, 00:00

  • Hospital Utilization in Patients Diagnosed with Peripheral Arterial Hypertension

    May 1, 2016, 00:00

  • CHARACTERIZATION OF INITIAL TREATMENT STRATEGIES USED TO MANAGE INCIDENT KNEE OSTEOARTHRITIS

    May 1, 2016, 00:00

  • Development of a Pharmacoeconomic Model to Assess the Cost Effectiveness of Pharmacogenomics Tests in Chronic Heart Failure- The Case of Ivabradine

    May 1, 2016, 00:00

  • Mining Patient Claim Data To Detect Drug Signals That Can Reduce The Risk Of Barrett’s Esophagus Patient Developing Esophageal Adenocarcinoma

    May 1, 2016, 00:00

  • CONTRIBUTION TO THE CLINICAL SAFETY AND ECONOMIC IMPACT THROUGH DETECTION OF MEDICATION ERRORS PERFORMED BY CLINICAL PHARMACISTS IN PATIENTS WITH HEMATOLOGIC DIAGNOSTICS- EXPERIENCE IN AN ONCOLOGY HOSPITAL IN MEXICO

    May 1, 2016, 00:00

  • Health Economic Evaluation Of Interferon Beta 1b Versus 1a For Patients Diagnosed With Relapsing Remitting Multiple Sclerosis

    May 1, 2016, 00:00

  • Impact of Out-Of-Pocket Costs on Medication Adherence among Patients with Type 2 Diabetes

    May 1, 2016, 00:00

  • Racial Disparities in Amputation Rates for the Treatment of Peripheral Artery Disease Using the Health Care Cost and Utilization Project Database

    May 1, 2016, 00:00

  • Assessing Factors Associated With Antipsychotic Polypharmacy In The Texas Medicaid Population

    May 1, 2016, 00:00

  • ASSESSING THE IMPACT OF SIMULATED TIME HORIZON ON PREDICTED INCREMENTAL QUALITY ADJUSTED LIFE YEARS IN TYPE 2 DIABETES

    May 1, 2016, 00:00

  • Are Meaningful Discussions About Adherence in Reimbursement Submissions of Chronic Diseases Hindered by Reporting Heterogeneity?

    May 1, 2016, 00:00

  • Cost And Resource Utilization Associated with Hospitalized Multiple Sclerosis Patients

    May 1, 2016, 00:00

  • Carbetocin In Prevention of Uterine Atony Following Delivery by Cesarean Section in Population Who Experienced Postpartum Hemorrhage- Costs in Polish Settings

    May 1, 2016, 00:00

  • Opportunity Cost And Health Impact Of Prenatal Care In Pregnant Women With Public Health Insurance In Colombia

    May 1, 2016, 00:00

  • Assure-Csu- Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity

    May 1, 2016, 00:00

  • Combining Multiple Data Sources In A Single Study- Strengths Of Hybrid Study Methodology

    May 1, 2016, 00:00

  • Estimating the Cost Per Percent Point Reduction in Ldl-C for Patients Treated with Pcsk9 Inhibitors in a Large National Health Plan

    May 1, 2016, 00:00

  • AGE, COHORT, AND HEALTH-RELATED QUALITY OF LIFE- AN AGE-PERIOD-COHORT ANALYSIS OF THE NATIONAL HEALTH INTERVIEW SURVEY

    May 1, 2016, 00:00

  • Development Of A Report Card For Identifying Local Sublingual Immunotherapy Events In Clinical Trials

    May 1, 2016, 00:00

  • Cost Consequence Analysis of Two Different Active Flowable Hemostatic Matrices in Cardiac Surgery Patients (Us Hospital Provider Perspective)

    May 1, 2016, 00:00

  • DO JOURNAL EDITORS PERCEIVE REAL-WORLD EVIDENCE AS VALUABLE?

    May 1, 2016, 00:00

  • Patient Perceptions of Psoriasis- A Review of the Survey Literature by Geography

    May 1, 2016, 00:00

  • VARIATIONS IN THE PRICES OF DRUGS FALLING UNDER THE NLEM

    May 1, 2016, 00:00

  • Prescribing Patterns For Patients With Prostate Cancer In The United States- 2006-2010

    May 1, 2016, 00:00

  • Demographic Characteristics of High Medication Spenders in a State Correctional System

    May 1, 2016, 00:00

  • Emergency Department Treatment Patterns of Patients with Epilepsy in the United States from 2008-2011- A Nationally Representative Analysis using Nhamcs Data

    May 1, 2016, 00:00

  • COSTS AND OUTCOMES OF TREATING HCV PATIENTS IN KAZAKHSTAN HEALTH CARE SYSTEM

    May 1, 2016, 00:00

  • VALIDITY AND RELIABILITY OF THE MALAYSIAN VERSION OF PARENT ATTITUDES ABOUT CHILDHOOD VACCINES (PACV) SURVEY

    May 1, 2016, 00:00

  • Treatment Patterns among Advanced Melanoma Patients in Europe

    May 1, 2016, 00:00

  • Literature Review- Epidemiology And Treatment Patterns In Epithelial Ovarian Cancer

    May 1, 2016, 00:00

  • BUDGET IMPACT OF USING EITHER ULTRASONIC ENERGY OR OTHER ENERGY DEVICES FOR TISSUE DISSECTION IN ADULT DEFORMITY SPINAL FUSION SURGERY

    May 1, 2016, 00:00

  • IMPROVEMENT IN IWQOL-LITE-DERIVED HEALTH UTILITY SCORE WITH LIRAGLUTIDE 3.0 MG VERSUS PLACEBO OVER 3 YEARS IN PREDIABETES

    May 1, 2016, 00:00

  • Systematic Review And Meta-Analysis Of Briakinumab, A Fully Human Interleukin 12/23 Monoclonal Antibody, For The Treatment Of Moderate To Severe Chronic Plaque Psoriasis

    May 1, 2016, 00:00

  • HARVONI ACCESS AND UTILIZATION TRENDS IN FIFTY MEDICAID PROGRAMS IN THE UNITED STATES

    May 1, 2016, 00:00

  • ADHERENCE OF INITIAL BIOLOGIC DURING THE SECOND YEAR IN RHEUMATOID ARTHRITIS PATIENTS WITH ONE YEAR OF EFFECTIVE TREATMENT

    May 1, 2016, 00:00

  • Use Of Databases For Health Resource Utilizaton And Cost Analyses In EU-5- Results From A Focused Literature Review

    May 1, 2016, 00:00

  • Systematic Review Of Design Of Latest Real-World Observational Studies In Multiple Myeloma

    May 1, 2016, 00:00

  • COMPARING HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG OBESE PATIENTS IN THE US MEDICAID POPULATION

    May 1, 2016, 00:00

  • Comparison Of Suicide Attempts/Behaviors Following Smoking Cessation Treatments Among Schizophrenic Smokers

    May 1, 2016, 00:00

  • Pan-Canadian Oncology Drug Review Recommendations for Cancer Products without Statistically Significant Overall Survival Data

    May 1, 2016, 00:00

  • Satisfaction of Clients with the Services of an Outpatient Pharmacy at a University Hospital in Northwestern Ethiopia- A Cross-Sectional Study

    May 1, 2016, 00:00

  • FEASIBILITY OF A PHONE-BASED MOTIVATIONAL INTERVIEWING INTERVENTION TO IMPROVE MEDICATION ADHERENCE BY PHARMACY STUDENTS ON ADVANCED PHARMACY PRACTICE EXPERIENCE ROTATION IN A MEDICARE ADVANTAGE WITH PRESCRIPTION DRUG PLAN

    May 1, 2016, 00:00

  • MICAFUNGIN FOR THE TREATMENT OF LIFE-THREATENING INVASIVE CANDIDIASIS IN THE INTENSIVE CARE UNIT SETTING IN SPAIN- A BUDGET IMPACT ANALYSIS

    May 1, 2016, 00:00

  • Newly Diagnosed Depression After Cancer Diagnosis Among Elderly With Breast, Colorectal, And Prostate Cancer

    May 1, 2016, 00:00

  • COST-UTILITY ANALYSIS IN HEPATITIS C VIRUS GENOTYPE 3 INFECTION- COMPARING THE NEW 12-WEEK REGIMEN WITH OTHER STANDARD THERAPIES

    May 1, 2016, 00:00

  • Validation of The Dhds- A Hybrid Instrument to Measure Health-Related Quality-Of-Life in Patients with Diabetes, Hypertension, and Dyslipidemia

    May 1, 2016, 00:00

  • PRICE ANALYSIS OF BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS MARKETED IN THE UNITED STATES

    May 1, 2016, 00:00

  • Use Of Home Health Services In Maternal And Infant Studies

    May 1, 2016, 00:00

  • Safety, Efficacy, and Pharmacokinetic Bioequivalence of Biosimilar Tumor Necrosis Factor-Alpha Inhibitors Compared with Their Reference Biologics- A Systematic Review

    May 1, 2016, 00:00

  • COMPARING MEDICATION ADHERENCE RATES BETWEEN PHARMACY DESERT AND NON-DESERT AREAS AMONG ELDERLY IN PENNSYLVANIA

    May 1, 2016, 00:00

  • The Value of New Anticancer Drugs

    May 1, 2016, 00:00

  • Assessing Patient-Perceived Barriers to Routine Counseling Services offered by Community Pharmacists

    May 1, 2016, 00:00

  • Racial Disparities in Amputation Rates Among Native Americans with Peripheral Artery Disease- Analysis of the Health Care Cost and Utilization Project Database

    May 1, 2016, 00:00

  • Prevalence, Patterns, And Predictors Of Psychotropic Polypharmacy Among Community-Dwelling Elderly Individuals With Parkinson’s Disease In The United States

    May 1, 2016, 00:00

  • Cross-Cultural Validation of Four Commonly used Symptoms Based Questionnaires to Assess Neuropathic Pain in Patients with Chronic Pain

    May 1, 2016, 00:00

  • Analysis of Real-World Evidence And Real-World Data By Conitec, Brazilian Hta Agency

    May 1, 2016, 00:00

  • SGLT2 INHIBITORS COMPARED WITH SITAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES- A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2016, 00:00

  • Cost Effectiveness of Intensive Lowering of Ldl Cholesterol with Pcsk9 Inhibitors as an Adjunct to High-Intensity Statin Therapy for Prevention of Major Vascular Events

    May 1, 2016, 00:00

  • Indirect Comparison Of Efficacy Of PonatiniB Versus Bosutinib In 3rd-Line Chronic-Phase Chronic Myeloid Leukemia Using Iterative Proportional Fitting

    May 1, 2016, 00:00

  • Assessment Of The Use Of Heterogeneity Of Treatment Effect Analyses In Cer And Future Directions

    May 1, 2016, 00:00

  • The Impact Of Socioeconomic Factors In The Prevalence Of Depression In Brazil Between 1998 And 2008

    May 1, 2016, 00:00

  • Over- And Underuse of Therapeutic and Palliative Care Services for Cancer Patients at End of Life- A Population-Based Study

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN PERU

    May 1, 2016, 00:00

  • DISSEMINATION OF SHV BETA-LACTAMASE GENES AMONGST CLINICAL ACINETOBACTER BAUMANNII ISOLATES

    May 1, 2016, 00:00

  • THE BURDEN OF TOPHACEOUS AND NON-TOPHACEOUS GOUT IN THE UNITED STATES

    May 1, 2016, 00:00

  • Economic and Clinical Evaluation of Electrostimulation in Medical Rehabilitation

    May 1, 2016, 00:00

  • ARE THE SMC GETTING NICER? A TIME-TREND ANALYSIS OF NICE AND SMC APPRAISAL OUTCOMES

    May 1, 2016, 00:00

  • Antibiotic Drugs Utilization Pattern in Two Tertiary Health Facilities in South East Nigeria- Implication for Bacterial Treatment

    May 1, 2016, 00:00

  • Health Care Utilization and Costs Associated with Breast and Female Genital System Cancers- An Analysis using the 2013 MEPS Database

    May 1, 2016, 00:00

  • Differences In HTA Acceptance Rates Across Disease Areas- A Comparison Between Four HTA Agencies

    May 1, 2016, 00:00

  • Final Year Pharmacy Students’ Perception towards Generic Medicines- A Questionnaire-Based Study from Yemen

    May 1, 2016, 00:00

  • Price Elasticity of Demand for New Oral Anticoagulant Agents among Patients with Non-Valvular Atrial Fibrillation

    May 1, 2016, 00:00

  • The Use Of Migraine Prophylaxis Treatment- Analysis Of Clinical Practice Data From The United States, Germany, France, And Japan

    May 1, 2016, 00:00

  • Cost Effectiveness Of Lurasidone, Quetiapine, And Olanzapine Monotherapy In The Treatment Of Bipolar I Disorder Depression

    May 1, 2016, 00:00

  • Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment- Pharmacoeconomic Analysis of a Prospective Randomized Trial

    May 1, 2016, 00:00

  • HOSPITAL PERFORMANCE ON QUALITY MESAURES- APPROACHES TO FAIR CROSS-HOSPITAL COMPARISONS AND VALUE-BASED PAYMENTS

    May 1, 2016, 00:00

  • Chinese Health System Development From 1949 To 2015- A Systematic Review

    May 1, 2016, 00:00

  • Retrospective Chart Review Study to Evaluate the Cost of Care of Patients with Symptomatic Multiple Myeloma in France

    May 1, 2016, 00:00

  • A LITERATURE REVIEW OF STUDY DESIGN ELEMENTS IN COST-EFFECTIVENESS ANALYSES

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF MACHINE PERFUSION USE AFTER LONG COLD ISCHEMIC TIME IN A KIDNEY TRANSPLANTATION PROGRAM

    May 1, 2016, 00:00

  • SATISFACTION WITH PHARMACY SERVICES IN DIABETIC DIALYSIS PATIENTS ENROLLED IN AN EYE CARE STUDY AT TWO CENTERS

    May 1, 2016, 00:00

  • ESTIMATED COST OF BUPIVACAINE LIPOSOMAL INJECTABLE SUSPENSION IN MEDICARE PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY USING PREMIER CHARGEMASTER DATA

    May 1, 2016, 00:00

  • Adoption Of Computed Tomography Image Guidance Among Hepatocellular Carcinoma Patients With Percutaneous Radiofrequency Ablation

    May 1, 2016, 00:00

  • Identification Of Persons With Congenital Hemophilia In A Large Electronic Health Record Database

    May 1, 2016, 00:00

  • STATIN TREATMENT ADHERENCE ASSOCIATED WITH TIME-VARYING PREDICTORS IN TAIWAN DIABETES PATIENTS

    May 1, 2016, 00:00

  • PREVALENCE OF DIABETIC RETINOPATHY IN THE UNITED STATES, 2011–2014

    May 1, 2016, 00:00

  • Comparison of Insulin And Non-Insulin Treatment Modification Within 90 Days of An Hba1c Greater Than or Equal To 9% On Diabetes Progression Rates In A Medicare Advantage Cohort Over 4 Years

    May 1, 2016, 00:00

  • Does Society Wish To Place Greater Weight On A Unit Of Health Gain For End-Of-Life Patients Than On That For Other Types Of Patients?

    May 1, 2016, 00:00

  • Formalizing Model Testing Methods- The Need For The Formation Of An Ispor Task Force On Model Testing Based On Software Engineering Best Testing Practices

    May 1, 2016, 00:00

  • IMPACT OF HYDROCODONE RESCHEDULING ON TEXAS PHYSICIANS’ FUTURE PAIN MANAGEMENT

    May 1, 2016, 00:00

  • Identification and Management of Canadian Patients with Symptoms of Statin Intoleran Results from a Real-World Clinical Practice Survey

    May 1, 2016, 00:00

  • ECONOMIC OUTCOMES AMONG SURGICAL PROCEDURES USING SURGICEL™ IN MEXICAN PUBLIC HEALTH CARE INSTITUTIONS

    May 1, 2016, 00:00

  • Real-Life Evidence in the Treatment of Gynecological Diseases in Ukraine- Use in Decision Making

    May 1, 2016, 00:00

  • Treatment Patterns In Attention Deficit Hyperactivity Disorder Among Texas Medicaid Preschoolers

    May 1, 2016, 00:00

  • THE ECONOMIC BURDEN OF THE BARIATRIC SURGICAL WAITING LINE

    May 1, 2016, 00:00

  • INCREMENTAL HEALTH CARE EXPENDITURES ASSOCIATED WITH DEPRESSION AMONG INDIVIDUALS WITH CUTANEOUS LUPUS ERYTHEMATOSUS

    May 1, 2016, 00:00

  • Pharmacy-Led Medication Reconciliation Programs at Hospital Transitions- A Systematic Review and Meta-Analysis

    May 1, 2016, 00:00

  • Use of A Saline-Coupled Bipolar Sealer And Cavitron Ultrasonic Surgical Aspirator During Open Liver Resection For Malignancy- Resource Use And Costs

    May 1, 2016, 00:00

  • Does the Mother’s Level of Education Influence Immunization Coverage?

    May 1, 2016, 00:00

  • Comorbidities and Symptoms among Endometriosis Patients- A Systematic Literature Review

    May 1, 2016, 00:00

  • Cost-Effectiveness and Cost-Utility Analysis Comparing Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas

    May 1, 2016, 00:00

  • Interval-Censored Survival Data Analysis- Learnings From Phase Iii Trial In Prostate Cancer

    May 1, 2016, 00:00

  • ECONOMIC IMPACT OF DENGUE IN TOURISM IN BRAZIL

    May 1, 2016, 00:00

  • ESTIMATED HOSPITAL COSTS ASSOCIATED WITH PREVENTABLE HEALTH CARE-ASSOCIATED INFECTIONS IF HEALTH CARE ANTISEPTIC PRODUCTS WERE UNAVAILABLE

    May 1, 2016, 00:00

  • PREDICTING TEXAS PHYSICIANS’ INTENTION TO PRESCRIBE HYDROCODONE COMBINATION PRODUCTS AFTER RESCHEDULING

    May 1, 2016, 00:00

  • Real-World Hepatitis C Treatment Strategies in the United Kingdom and Denmark

    May 1, 2016, 00:00

  • BRAND NAME DRUG UTILIZATION AMONG MEDICAID PATIENTS IN 340B CLINICS

    May 1, 2016, 00:00

  • DESIGN AND DEVELOPMENT OF AN INTELLIGENT DRUG ALERT SYSTEM FOR ENFORCING MEDICATION SAFETY

    May 1, 2016, 00:00

  • CONSUMER INVOLVEMENT AND COGNITIVE EFFORT- INTERACTION AND EFFECT ON INFORMATION PROCESSING OF PRESCRIPTION DRUG INFORMATION LEAFLETS

    May 1, 2016, 00:00

  • A Pilot Study Using Electronic Medical Records To Evaluate The Mortality And Health Service Utilization In Cancer Patients With Depression At A Medical Teaching Oncology Center

    May 1, 2016, 00:00

  • COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

    May 1, 2016, 00:00

  • Evaluation of Daa (Direct-Acting Antiviral) Access Across the United States- The Interplay Between Hepatitis C Patient and Insurance Type

    May 1, 2016, 00:00

  • Estimating the Future Burden of Cardiovascular Disease in China and the Potential Value of Universal Lipid and Blood Pressure Control

    May 1, 2016, 00:00

  • Relationship Between Health-Related Quality of Life and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients with No Prior Chemotherapy- Results from Prevail Study

    May 1, 2016, 00:00

  • IMPACT OF HEALTH INFORMATION SYSTEMS ON HOSPITAL BED OCCUPANCY RATES IN FRENCH HOSPITALS- RESULTS FROM THE E-SI (PREPS-SIPS) STUDY

    May 1, 2016, 00:00

  • Clinical and Economic Burden of Mental Disorders in Children with Chronic Physical Conditions in the United States

    May 1, 2016, 00:00

  • A Review of Hepatitis C Databases and Registries across the World

    May 1, 2016, 00:00

  • Health Care Resource Utilization among Advanced Melanoma Patients in Europe

    May 1, 2016, 00:00

  • COMPARISON OF PARENT AND NON-PARENT PREFERENCES IN THE VALUATION OF CHILD HEALTH

    May 1, 2016, 00:00

  • A Quality-Of-Life Study for People Aged 65 Years and Older in Hungary

    May 1, 2016, 00:00

  • Economic Burden Of Hematopoietic Cell Transplant Among Patients With Hematologic Malignancies

    May 1, 2016, 00:00

  • Use of a Decision Analytic Model to Assess the Clinical and Economic Impact of an Educational Program for Antimicrobial Use in a Dialysis Clinic

    May 1, 2016, 00:00

  • Health Economic Evaluation Of Orally Versus Subcuteanously Administered Disease Modifying Therapies For Patients Diagnosed With Relapsing Remitting Muliple Sclerosis

    May 1, 2016, 00:00

  • ESTIMATING THE LIFETIME PRICE OF PHARMACEUTICALS- WHAT ARE THE LONG-TERM COSTS TO SOCIETY?

    May 1, 2016, 00:00

  • Association Between The Use Of Doxorubicin And Risk Of Developing Hepatotoxicity Among Cancer Patients

    May 1, 2016, 00:00

  • Clinical and Economic Burden of Peripheral Artery Disease Among Patients Receiving Endovascular Interventions- A Retrospective Cohort Study of Commercially Insured Patients in the United States

    May 1, 2016, 00:00

  • ALL-CAUSE MORTALITY OF DIABETES PATIENTS AFTER LOWER EXTREMITY AMPUTATIONS

    May 1, 2016, 00:00

  • CHANGES IN QUALITY OF CARE ASSOCIATED WITH CENTRALIZATION OF ELECTIVE ORTHOPAEDIC SURGERY PROCEDURES- A SCOPING REVIEW

    May 1, 2016, 00:00

  • A Patient-Centric Outcomes Research Study With A Branded Proton-Pump Inhibitor In A Community Pharmacy Setting- Feasibility And Implementation Of A Real-World Observational Outcomes Research Study

    May 1, 2016, 00:00

  • THE COST EFFECTIVENESS OF AFAMELANOTIDE FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORHYRIA

    May 1, 2016, 00:00

  • Did a Physician-Targeted Intervention that Reduced Potentially Inappropriate Prescribing to Elderly Patients also Reduce Related Hospitalizations?

    May 1, 2016, 00:00

  • US AND LATIN AMERICA- FINDING THE BEST BASE FOR SPANISH ADAPTATIONS

    May 1, 2016, 00:00

  • Impact of Ldl-C Goal Attainments and Cost of Management Following the 2013 Acc/Aha Guideline Among Statin Users in Hong Kong Chinese- Real-World Results

    May 1, 2016, 00:00

  • THE TREATMENT OF POSTHERPETIC NEURALGIA REVEALS WIDESPREAD USE OF OPIOIDS, CNS DEPRESSANTS, AND POLYPHARMACY

    May 1, 2016, 00:00

  • INFLAMMATORY BOWEL DISEASE- COST-DRIVING FACTORS AND THE IMPACT OF COST-SHARING ON OUTPATIENT UTILIZATION

    May 1, 2016, 00:00

  • Optimal Minimum Length Of Treatment With Buprenorphine- An Analysis Of Resource Use And Costs After Medically Controlled Discontinuation

    May 1, 2016, 00:00

  • COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB

    May 1, 2016, 00:00

  • The Burden of Multiple Sclerosis in Japan

    May 1, 2016, 00:00

  • EFFICACY AND SAFETY OF RITUXIMAB FOR SYSTEMIC LUPUS TREATMENT- SYSTEMATIC REVIEW

    May 1, 2016, 00:00

  • EVALUATING HUMANISTIC OUTCOMES FOR ORAL CANCER PATIENTS IN INDIA- A SYSTEMATIC LITERATURE

    May 1, 2016, 00:00

  • PERCEIVED IMPACT OF PATIENT INPUT ON HTA DECISIONS- COMMON VERSUS SPECIALTY DRUGS AND PATIENTS CF. NON-PATIENTS

    May 1, 2016, 00:00

  • DIRECT ECONOMIC BURDEN AND OUTCOMES AMONG PATIENTS WITH CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION OR COLONIZATION

    May 1, 2016, 00:00

  • WHAT IMPACTS THE QUALITY OF COMPARATIVE-EFFECTIVENESS RESEARCH- A CLASSIFICATION AND REGRESSION TREE ANALYSIS USING THE GRACE CHECKLIST

    May 1, 2016, 00:00

  • Budget Impact Analysis of the Incorporation of Ibrutinib for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in the Brazilian Private Health Care System

    May 1, 2016, 00:00

  • The Persistence of Golimumab in Daily Clinical Practice for the Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis- Analysis of Prospectively Collected Data in the Slovenian National Online Registry of Patien ...

    May 1, 2016, 00:00

  • THE DISTRIBUTION OF THE EQ-5D-5L INDEX IN PATIENTS POPULATIONS

    May 1, 2016, 00:00

  • MAPPING CANINE LEPTOSPIROSIS RISK IN THE UNITED STATES

    May 1, 2016, 00:00

  • Antidepressant Usage Patterns Of Patients With Major Depressive Disorder Initiated On Snris Compared With Ssris In Beijing, China

    May 1, 2016, 00:00

  • THE EVALUATION OF GENERIC MANUFACTURUERS’ PRODUCT CHARACTERISTICS IN MAJOR MTM CHRONIC DISEASE MEDICATION CLASSES- A POTENTIAL SOURCE OF NON-ADHERENCE

    May 1, 2016, 00:00

  • IMPORTANT ASPECTS OF (FULL) HEALTH NOT CAPTURED BY EQ-5D

    May 1, 2016, 00:00

  • Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia

    May 1, 2016, 00:00

  • UTILIZATION PATTERN OF PRESCRIPTION PAIN MEDICATION AMONG ADULTS WITH DIABETES MELLITUS

    May 1, 2016, 00:00

  • Medicare Part D Cost Sharing And Specialty Drug Initiation In Newly Diagnosed Chronic Myeloid Leukemia Patients

    May 1, 2016, 00:00

  • Analysis of the Results Obtained when Treating Patients with Rheumatoid Arthritis with Biological Therapy in the Costa Rican Social Security System (Caja Costarricense De Seguro Social - Ccss)

    May 1, 2016, 00:00

  • ANTIRETROVIRALS AND CO-PRESCRIBED DRUGS FOR PEOPLE LIVING WITH HIV/AIDS IN A UNIVERSITY TEACHING HOSPITAL, SOUTH WEST NIGERIA

    May 1, 2016, 00:00

  • IMPROVING PATIENT SAFETY THROUGH COMMUNICATION- A BRAZILIAN PERSPECTIVE

    May 1, 2016, 00:00

  • Bayesian Analysis Of Single Arm Trials- Concepts And Examples

    May 1, 2016, 00:00

  • Socioeconomic Determinants of Nutritional Status in Outpatients Under Five in a Pediatric Hospital of Colombia

    May 1, 2016, 00:00

  • ATTRIBUTE IDENTIFICATION OF CAREGIVERS’ TRADEOFFS IN CARE MANAGEMENT DECISION MAKING FOR INDIVIDUALS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS

    May 1, 2016, 00:00

  • BUDGET IMPACT ANALYSIS OF THE INCLUSION OF TOFACITINIB AS AN ALTERNATIVE FOR RHEUMATOID ARTHRITIS TREATMENT AFTER CONVENTIONAL DMARDS FAILURE IN CHILE

    May 1, 2016, 00:00

  • IMPACT OF PHARMACEUTICAL CARE INTERVENTIONS ON TYPE 2 DIABETES IN A TERTIARY HOSPITAL IN NIGERIA- EXPLORING THE FRONTIER

    May 1, 2016, 00:00

  • A Costs And Clinical Outcomes Predicting Model For A Wound Care Outcomes-Based Risk-Sharing Agreement Proposal In Colombia

    May 1, 2016, 00:00

  • Characteristics And Health Care Utilization Among Adults With Chronic Obstructive Pulmonary Disease According To Missed Work Status- A Retrospective Analysis Of The Medical Expenditure Panel Survey

    May 1, 2016, 00:00

  • Determining And Identifying Costs For Economic Evaluations- Guidance From Canada

    May 1, 2016, 00:00

  • Accounting for Rater Severity/Leniency in Endpoint Measures in Adults with Severe TBI

    May 1, 2016, 00:00

  • The Burden Of Staple Line Interventions In Colorectal Surgery

    May 1, 2016, 00:00

  • ELICITING PATIENT PREFERENCES FOR TREATMENT OUTCOMES IN SYSTEMIC LUPUS ERYTHMATOSUS

    May 1, 2016, 00:00

  • A Systematic Literature Review of Comorbidities and Symptoms among Uterine Fibroids Patients between 2000 and 2013

    May 1, 2016, 00:00

  • Cost-Effectiveness of Dulaglutide, Liraglutide, And Glargine In Adult Patients With Diabetes Mellitus In Colombia

    May 1, 2016, 00:00

  • Compounding Pharmacies- Workers’ Compensation Cost

    May 1, 2016, 00:00

  • Do Accepted Techniques for Indirect Comparative Effectiveness Reflect the need for Individualized Patient Care in Heterogeneous Populations? The Case of Brivaracetam Versus Adjunctive Antiepileptic Medications for the Treatment of Adult Pat ...

    May 1, 2016, 00:00

  • EFFICACY OF THE MICA ANTIBODY FOR TRANSPLANT PATIENTS

    May 1, 2016, 00:00

  • Health Care Expenditures Associated With Persistent Emergency Department Use- A Multi-State Analysis of Medicaid Beneficiaries

    May 1, 2016, 00:00

  • Treatment and Patient Burden in ER+ HER2- Metastatic Breast Cancer- Results From a Physician Survey in the United States

    May 1, 2016, 00:00

  • Persistence and Compliance with Cardiovascular Drug Therapy Among Seniors

    May 1, 2016, 00:00

  • Biologics Switching Patterns and Associated Costs in Psoriasis Patients in a Large Commercially Insured Population in the United States

    May 1, 2016, 00:00

  • Impact of Medication Adherence on Hospitalization in Medicaid

    May 1, 2016, 00:00

  • Incidence Rates Of Patients Starting Treatment For Chronic Lymphocytic Leukemia In The Brazilian Public Health Care System- A Retrospective Epidemiologic Study Based On Datasus

    May 1, 2016, 00:00

  • Health Care Utilization and Costs Associated with Potential Refractory Epilepsy in Texas Medicaid

    May 1, 2016, 00:00

  • UTILIZATION AND EXPENDITURES IN ANTI-TUMOR NECROSIS FACTOR DRUGS IN MEDICARE PART D IN 2013- A CROSS-SECTIONAL ANALYSIS

    May 1, 2016, 00:00

  • COMPARISON OF PROPENSITY SCORE WITH ZIP MODELS IN ANALYZING ZERO-INFLATED COUNT DATA IN OBSERVATIONAL STUDIES

    May 1, 2016, 00:00

  • Cost And Clinical Outcomes Of A Pharmacist-Led Intervention Program To Reduce Utilization High-Risk Sedative Hypnotics And Skeletal Muscle Relaxants In The Elderly Population With Depression

    May 1, 2016, 00:00

  • ASSESSMENT OF ENDOCRINOLOGISTS ABOUT DRUGS PRESCRIPTIONS FOR THYROID DISEASE PHARMACOTHERAPY IN UKRAINE

    May 1, 2016, 00:00

  • Costs Of End-Of-Life Treatments Among Elderly Metastatic Colon Cancer Patients

    May 1, 2016, 00:00

  • MEDICATION ADHERENCE- DOES ADHERENCE TO SOME THERAPEUTIC CLASSES IMPROVE ADHERENCE TO OTHERS?

    May 1, 2016, 00:00

  • Economic Impact of Health Care Resource Utilization Pattern Among Patients Diagnosed with Cervical Dysplasia and Cervical Cancer in Costa Rica

    May 1, 2016, 00:00

  • Effect of Patient-Reported Symptoms on Medication Adherence in Hypertensive Patients

    May 1, 2016, 00:00

  • TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE- A CANADIAN COST-UTILITY ANALYSIS

    May 1, 2016, 00:00

  • HEALTH-RELATED QUALITY OF LIFE OF HIV/AIDS PATIENTS ON HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY AT A UNIVERSITY REFERRAL HOSPITAL IN ETHIOPIA

    May 1, 2016, 00:00

  • PREDICTING NON-INSULIN ANTIDIABETIC DRUG ADHERENCE USING A THEORETICAL FRAMEWORK BASED ON THE THEORY OF PLANNED BEHAVIOR IN ADULTS WITH TYPE 2 DIABETES- A PROSPECTIVE STUDY

    May 1, 2016, 00:00

  • Author Index

    May 1, 2016, 00:00

  • A Systematic Review to Assess the Impact of Non-Adherence to Treatments on Health Care Cost in Chronic Myeloid Leukemia

    May 1, 2016, 00:00

  • Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided In US Food And Drug Administration Drug Labels- An Update

    May 1, 2016, 00:00

  • A REVIEW OF PRICING OF ORPHAN DRUGS FOR LEUKEMIA IN THE UNITED STATES VERSUS ENGLAND

    May 1, 2016, 00:00

  • Access To Health Care In Argentina. The Role Of Geography And Other Factors Affecting Health Coverage Across Large Urban Centers

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF LENVATINIB, SORAFENIB, AND PLACEBO IN TREATMENT OF RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER

    May 1, 2016, 00:00

  • Assessment of Drug Utilization Practice in Ophthalmology Department of University of Gondar Referral and Teaching Hospital, North West Ethiopia

    May 1, 2016, 00:00

  • Development and Evaluation of a Crosswalk between the Eq-5d-5l And Menopause-Specific Quality of Life (Menqol) Questionnaire in Postmenopausal Women

    May 1, 2016, 00:00

  • Rescue Medication Use In Copd- Payer And Regulatory Perspective

    May 1, 2016, 00:00

  • Cost Effectiveness of Sorafenib Versus SBRT for Advanced Hepatocellular Carcinoma

    May 1, 2016, 00:00

  • ANALYSIS OF THE ULTRA-ORPHAN DRUGS APPROVED BY THE FDA IN THE PERIOD 1983-2014

    May 1, 2016, 00:00

  • Lung Cancer Management in China- Treatment Disparities that Need to be Resolved

    May 1, 2016, 00:00

  • ITEMS SELECTION FOR A PATIENT-REPORTED SYNDROME SCALE- PHLEGM SYNDROME (PRS-PS)

    May 1, 2016, 00:00

  • Cases And Meaning of Multiple Criteria Decision Analyses In The Real World- Overview Real Cases And Speculations For Korean Settings

    May 1, 2016, 00:00

  • Post-Operative Pain Management Association With Health Economic Outcomes

    May 1, 2016, 00:00

  • Burden of Disease and Health Care Costs of Patients Over 50 with Parkinson’s Disease in a Big Real-World Database (ARCO)

    May 1, 2016, 00:00

  • A LITERATURE REVIEW OF FACTORS AFFECTING PRICE AND COMPETITION IN THE GLOBAL PHARMACEUTICAL MARKET

    May 1, 2016, 00:00

  • An Assessment of Health-State Utilities in Metastatic Breast Cancer in the United Kingdom

    May 1, 2016, 00:00

  • Monitoring of Health Care Utilization 3 Months Prior to A Chronic Obstructive Pulmonary Disease

    May 1, 2016, 00:00

  • A Retrospective Study To Compare The Medication Costs Of An Hiv Population In State Correctional Facilities Between The Physician-Managed And Pharmacist-Managed Groups

    May 1, 2016, 00:00

  • A Preliminary Analysis Of Health Care Resource Utilization Of Paliperidone Palmitate In The Treatment Of Schizophrenia In The Public Health Care Sector Of Hong Kong

    May 1, 2016, 00:00

  • Annual Fatal and Non-Fatal Cardiovascular Event Costs among Non-Elderly Commercially Insured Adults with Hyperlipidemia in the United States

    May 1, 2016, 00:00

  • Treatment Patterns Of Antiepileptic Drugs In Patients With Potential Refractory Epilepsy In The Texas Medicaid Program

    May 1, 2016, 00:00

  • TIME UNTIL INSULIN INITIATION FOR CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN DUAL AND TRIPLE THERAPY FOR TYPE 2 DIABETES MELLITUS IN THE UNITED KINGDOM

    May 1, 2016, 00:00

  • A COMPARISON OF TOTAL HOSPITALS COSTS FOR MEDICARE PATIENTS UNDERGOING TOTAL KNEE ARTHROPLASTY WITH OR WITHOUT BUPIVACAINE LIPOSOMAL INJECTABLE SUSPENSION

    May 1, 2016, 00:00

  • Overview of National Leading Organizations Involved in Quality of Care in Oncology

    May 1, 2016, 00:00

  • TREND IN ORAL ANTIDIABETICS USE AMONG MOROCCAN PATIENTS

    May 1, 2016, 00:00

  • COST-UTILITY OF PCR DETECTION AMONG PATIENTS WITH SUSPECTED PERITONEAL CANDIDIASIS IN THE INTENSIVE CARE UNIT- A MODEL SIMULATION

    May 1, 2016, 00:00

  • A Review of Current Quality Metrics for Evaluating Patient-Centered Medical Homes

    May 1, 2016, 00:00

  • PATTERNS OF BIOEQUIVALENCE RECOMMENDATIONS AND TRENDS OF ABBREVIATED NEW DRUG APPLICATIONS APPROVAL OVER TIME

    May 1, 2016, 00:00

  • A Cross-Sectional Assessment of Knowledge, Attitude, and Practice on Hepatitis B and C Patients in Ayub Medical Complex Abbottabad, Pakistan

    May 1, 2016, 00:00

  • A Review of the Burden of Lung Cancer in China

    May 1, 2016, 00:00

  • COST EFFECTIVENESS OF A MINIMALLY INVASIVE CELL SAMPLING DEVICE TO SCREEN FOR BARRETT’S ESOPHAGUS IN PATIENTS WITH GERD SYMPTOMS

    May 1, 2016, 00:00

  • PHARMACOEPIDEMIOLOGY OF CROHN’S DISEASE MANAGEMENT IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2016, 00:00

  • SMARTPHONE-ENHANCED RAPID INFLUENZA TESTS- A COST-EFFECTIVENESS ANALYSIS

    May 1, 2016, 00:00

  • Evaluation of the Performance Properties of the Influenza Patient-Reported Outcomes Instrument (Flu-Pro)

    May 1, 2016, 00:00

  • Risk-Adjusted Hospital Rates Of Readmission And Mortality Using Comorbidity Data From A Clinical Registry Versus Administrative Claims

    May 1, 2016, 00:00

  • Methods For Synthesizing Costing Data- An Illustrative Example And Conceptual Methods Framework

    May 1, 2016, 00:00

  • Instructions for Authors

    May 1, 2016, 00:00

  • STRATEGIC MANAGEMENT CYCLE AND HEALTH SYSTEM FUNCTIONS MODEL APPLIED TO PHARMACEUTICAL POLICIES IN LATIN AMERICA

    May 1, 2016, 00:00

  • Cost-Utility Analysis of Erlotib Versus Standard Chemotherapy in First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in Vietnam

    May 1, 2016, 00:00

  • Fingolimod Versus Teiflunomide- Characteristics Of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis And Taking Oral Disease Modifying Therapies

    May 1, 2016, 00:00

  • Comparing Health Care Utilization Among Three Treatment Regimens Provided To Commercially-Insured Patients With Chronic Hepatitis C Virus Genotype 1

    May 1, 2016, 00:00

  • Budgetary Impact Analysis of Levetiracetam use for Focal Epilepsy Patients’ Treatment with or without Secondary Generalization from the Brazilian Public Health System Perspective

    May 1, 2016, 00:00

  • A PROPOSED RUBRIC FOR PATIENT ENGAGEMENT IN DRUG DEVELOPMENT- WHAT CONSTITUTES “SOUND” ENGAGEMENT?

    May 1, 2016, 00:00

  • Survey Metrics For Surveys Using Administrative Data As The Sampling Frame

    May 1, 2016, 00:00

  • DRUG USAGE ANALYSIS AND MEDICATION EXPENSES IN PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICAL THERAPY IN COLOMBIA

    May 1, 2016, 00:00

  • AGE AND GENDER DISTRIBUTION OF OUTPATIENT CARE PHYSIOTHERAPY SERVICES FOR WRIST AND HAND INJURIES IN HUNGARY

    May 1, 2016, 00:00

  • Cost Per Responder Analysis from the Checkmate 025 Phase III Trial of Nivolumab Versus Everolimus in Previously Treated Patients with Advanced Renal Cell Carcinoma

    May 1, 2016, 00:00

  • JOB SATISFACTION SURVEY OF PHYSICIANS WORKING AT THE CLINICAL CENTRE OF THE UNIVERSITY OF PÉCS

    May 1, 2016, 00:00

  • PHARMACOECONOMIC ASSESSMENT OF QUADROTHERAPY WITH ORIGINAL BISMUTH SUBCITRATE DRUG VERSUS QUADROTHERAPY WITH GENERIC DRUG IN PATIENTS WITH PEPTIC ULCER ASSOCIATED WITH HELICOBACTER PYLORI IN UKRAINE

    May 1, 2016, 00:00

  • HEALTH PLAN COVERAGE FOR MEDICAL DEVICES AND THE USE OF ELECTRONIC MEDICAL RECORD SYSTEMS

    May 1, 2016, 00:00

  • CHARACTERISTICS OF CHINESE PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS WHO WERE NOT INITIATED ON INSULIN

    May 1, 2016, 00:00

  • RECENT HEPATITIS C SCREENING TRENDS- AN ANALYSIS OF DATA FROM A LARGE US LABORATORY SERVICE PROVIDER

    May 1, 2016, 00:00

  • BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2016, 00:00

  • COMPARING THE EPIDEMIOLOGY, COST, AND QUALITY OF LIFE OF RHEUMATOID ARTHRITIS IN CHINA WITH THE REST OF THE WORLD

    May 1, 2016, 00:00

  • Psychopharmacotherapy And Health-Related Quality Of Life- Analysis Of Medical Expenditure Panel Survey

    May 1, 2016, 00:00

  • Improvement In Antihypertensive And Cholesterol-Lowering Medication Persistence Using A Mobile Technology Application

    May 1, 2016, 00:00

  • Income Growth Trajectory For Parents Of Children With Down Syndrome In The United States

    May 1, 2016, 00:00

  • DETERMINING THE FEASIBILITY OF USING A REGRESSION DISCONTINUITY APROACH TO COMPARE INPATIENT UTILIZATION BETWEEN MEDICAID FEE FOR SERVICE AND COMMERCIALLY OBTAINED COVERAGE IN THE ACA MEDICAID EXPANSION POPULATION

    May 1, 2016, 00:00

  • IMPROVING PRECISION BY APPLYING DISEASE PROGRESSION EQUATIONS FROM MULTIPLE SOURCES IN THE ALZHEIMER’S DISEASE ARCHIMEDES CONDITION EVENT (ACE) SIMULATOR

    May 1, 2016, 00:00

  • Cost Effectiveness of Dose Optimized Ustekinumab Versus Switching to Anti-Tnfs Following Partial Response to Ustekinumab Every Twelve Weeks in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2016, 00:00

  • Mortality And Rehospitalization Rates Among Patients With Chronic Obstructive Pulmonary Disease In The Us Medicare Population

    May 1, 2016, 00:00

  • Temporal Trends in Utilization of Pancreatectomy Procedures in New York State- 1999-2014

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS OF SILVER ALGINATE FOR INFECTED HARD-TO-HEAL WOUNDS TREATMENT IN BRAZIL

    May 1, 2016, 00:00

  • Determination Of Medication Errors And Economic Implications To One Year Of The Establishment Of Clinical Pharmacy Service In Medical Oncology Unit- Experience In A Hospital Of Cancer In Mexico

    May 1, 2016, 00:00

  • PROJECTING THE BURDEN OF CHRONIC DISEASES IN THE UNITED STATES FROM 2016 TO 2025 UNDER DIFFERENT SCENARIOS USING A MICROSIMULATION APPROACH

    May 1, 2016, 00:00

  • Cost-Utility Analysis of Ulipristal Acetate 5mg for Treating Patients with Uterine Fibroids in South Korea

    May 1, 2016, 00:00

  • A RISK EQUATION TO ESTIMATE IRON OVERLOAD-RELATED COMPLICATION RATES BASED ON ADHERENCE RATES OF IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT THALASSEMIA

    May 1, 2016, 00:00

  • COST-EFFECTIVENESS ANALYSIS OF DIABETIC NEPHROPATHY MANAGEMENT

    May 1, 2016, 00:00

  • FDA PATIENT-REPORTED OUTCOME LABELING OF NOVEL THERAPIES (2011-2015)

    May 1, 2016, 00:00

  • Racial and Ethnic Differences in the Use of Preventive Services among Cancer Survivors in the Medicare Program

    May 1, 2016, 00:00

  • Costs Of Cancer From The Patient/Caregiver Perspective

    May 1, 2016, 00:00

  • COST CONSEQUENCE ANALYSIS OF TWO DIFFERENT ACTIVE FLOWABLE HEMOSTATIC MATRICES IN SPINE SURGERY PATIENTS (US HOSPITAL PROVIDER PERSPECTIVE)

    May 1, 2016, 00:00

  • The Effect of Multimorbidity on Patient-Physician Communication and Trust among Elderly Medicare Beneficiaries with Chronic Conditions

    May 1, 2016, 00:00

  • BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2016, 00:00

  • Fingolimod Versus Teiflunomide- Health Care Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Therapies In The United States

    May 1, 2016, 00:00

  • IDENTIFYING FACTORS WHICH INFLUENCE THE SELECTION OF ANTI-TNF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ENGLAND

    May 1, 2016, 00:00

  • Quantifying the Association between Health-Related Quality of Life Scores and Subsequent Health Resource Utilization in Oncology

    May 1, 2016, 00:00

  • ORITAVANCIN IS ASSOCIATED WITH IMPROVED ECONOMIC OUTCOMES VERSUS DALBAVANCE IN PATIENTS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS TREATED IN A HOSPITAL OPAT SETTING- RESULTS FROM AN OBSERVATIONAL DATABASE

    May 1, 2016, 00:00

  • Hypofractionated Radiotherapy For Low-Intermediate Risk Prostate Cancer- Clinical And Economic Evaluation In A Real-Life Setting

    May 1, 2016, 00:00

  • ADHERENCE TO BISPHOSPHONATE THERAPY IN POSTMENOPAUSAL ROMANIAN OSTEOPOROTIC WOMEN WITH HYPERTENSION

    May 1, 2016, 00:00

  • HOW STAKEHOLDERS ARE RESPONDING TO ICER DRUG THERAPY REPORTS- AN ANALYSIS OF PUBLIC COMMENTS

    May 1, 2016, 00:00

  • BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2016, 00:00

  • EFFICACY AND SAFETY OF DULAGLUTIDE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS- A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2016, 00:00

  • Hospitalization Cost of Chiari Malformation Type I Surgery in PediatRIC Patients

    May 1, 2016, 00:00
  • «
  • 81 (current)
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »